Immunoassay Instruments Market Analysis Report with Business Overview, ChallengePosted by Rahul Gautam on July 18th, 2018 The immunoassay instruments market is growing with a considerable rate due to rising incidence of chronic infectious diseases, increasing preference for personalized medicine, and technological advancements. Investments in emerging economies, and focus on developing compact, reliable and portable immunoassay instruments are some of the factors giving ample opportunities to the immunoassay instruments market to grow in the coming years. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/immunoassay-instruments-market/report-sample The immunoassay instruments market can be categorized on the basis of applications as oncology, endocrinology, autoimmune disorders, bone and mineral disorders, allergy, infectious diseases, neonatal screening, hematology, blood screening, cardiology, stool testing, and toxicology. On the basis of end users, the immunoassay instruments market can be categorized as laboratories, pharmaceutical companies, academic research centers, hospitals, patient self testing, biotechnology companies, ambulatory centers, blood banks, and physician’s offices. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/immunoassay-instruments-market On the basis of technology, the immunoassay instruments market can be categorized as enzyme-linked immunosorbent assay (ELISA), radioimmunoassay, rapid tests, polymerase chain reaction, western blot, and ELISPOT. Enzyme-linked immunosorbent assay includes 1st generation ELISA tests, 2nd generation ELISA tests, 3rd generation ELISA tests and 4th generation ELISA tests. Some of the factors driving the immunoassay instruments market are enhanced discovery of specific biomarkers, extensive use of immunoassays in oncology and rising geriatric population. Implementation of excise duty by the U.S. government and high cost associated with technologically advanced immunoassay systems are some of the factors restraining the immunoassay instruments market to some extent. North America dominates the immunoassay instruments market due to expanding biotechnology and pharmaceutical industries, rising incidences of chronic diseases, government support and the launch of new products in the region. Asia-Pacific is expected to grow at the highest rate in the coming years. Some of the competitors in the immunoassay instruments market are Beckman Coulter, Inc., F. Hoffman-La Roche, Ltd., Thermo Fisher Scientific, Ortho Clinical Diagnostics, BioMerieux, Inc., Abbott Laboratories, Sysmex Corporation, DiaSorin S.p.A., Siemens Healthcare, and Merck Millipore Corporation. About P&S Intelligence P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. Contact: Like it? Share it! More by this author |